HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,662,827 | +16.1% | 46,100 | +22.9% | 0.18% | +1.1% |
| Q1 2023 | $1,432,125 | +231.2% | 37,500 | +393.4% | 0.18% | +181.0% |
| Q4 2022 | $432,440 | -32.1% | 7,600 | -52.8% | 0.06% | -51.2% |
| Q3 2022 | $637,000 | -27.3% | 16,100 | -19.1% | 0.13% | -20.9% |
| Q2 2022 | $876,000 | +147.5% | 19,900 | +155.1% | 0.16% | +77.2% |
| Q2 2021 | $354,000 | +0.3% | 7,800 | -7.9% | 0.09% | +13.6% |
| Q1 2021 | $353,000 | -23.6% | 8,465 | -62.9% | 0.08% | -13.8% |
| Q4 2017 | $462,000 | +376.3% | 22,800 | +103.6% | 0.09% | +62.1% |
| Q2 2016 | $97,000 | – | 11,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |